L
Luminex
We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, flow cytometry and imaging, genomic and proteomic research, and food safety
At a glance
- Founded
- 1995
- Headquarters
- Austin, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Alumni founders
Former Luminex employees who went on to found companies, sorted by Dealroom signal score.
PBPattern BioscienceEst. 2016
Nicolas ArabUnited States
ABA-Alpha BioEst. 2017
John C. CarranoUnited States
Gail PageUnited StatesGlobal footprint
team presence
Patents
71 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Luminex was the backer or acquirer, 2011–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Luminex's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Luminex deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Luminex's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Luminex on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Luminex on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.